Pendred's Syndrome and Genetic Defects in Thyroid Hormone Synthesis

Reviews in Endocrine and Metabolic Disorders

Volumn 1, Issue 1-2, 2000, Pages 109-121

  Kopp, Peter ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Congenital hypothyroidism; Hormone; Pendred's syndrome; Sodium iodide symporter; Thyroglobulin; Thyroid; Thyroperoxidase; Transcription factor

Indexed keywords

CARRIER PROTEIN; PERCHLORIC ACID; SLC26A4 PROTEIN, HUMAN; SODIUM DERIVATIVE; SODIUM PERCHLORATE; THYROID HORMONE;

BIOSYNTHESIS; GENETICS; GOITER; HEARING IMPAIRMENT; HUMAN; HYPOTHYROIDISM; MUTATION; PHYSIOLOGY; REVIEW; SYNDROME;

CARRIER PROTEINS; DEAFNESS; GOITER; HUMANS; HYPOTHYROIDISM; MEMBRANE TRANSPORT PROTEINS; MUTATION; PERCHLORIC ACID; SODIUM COMPOUNDS; SYNDROME; THYROID HORMONES;

EID: 0033762041     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1010024722595     Document Type: Article

References (93)

1. DeGroot LJ. Congenital defects in thyroid hormone formation and action. In: DeGroot LJ (ed.). Endocrinology. Philadelphia: W.B. Saunders, 1994:871-892.
2. Medeiros-Neto G, Stanbury JB. Inherited disorders of the thyroid system. Boca Raton: CRC Press, 1994.
3. Vassart G, Dumont JE, Refetoff S. Thyroid disorders. In: Beaudet AL, Seriver CR, Sly WS, Vale D (eds.). The metabolic basis of inherited disease. 7 ed. New York: McGraw-Hill, 1995:2883-2928.
4. Kopp P. Pendred's syndrome: clinical characteristics and molecular basis. Curr Concept Endocrinol Metab 1999;6:261-269.
5. Pendred V. Deaf-mutism and goitre. Lancet 1896;2:532.
6. Morgans ME, Trotter WR. Association of congenital deafness with goitre: the nature of the thyroid defect. Lancet 1958;1:607-609.
7. Fraser GR. Association of congenital deafness with goitre (Pendred's syndrome). Ann Hum Genet 1965;28:201-249.
8. Medeiros-Neto G, Stanbury JB. Pendred's syndrome: association of congenital deafness with sporadic goiter. In: Medeiros-Neto G, Stanbury JB (eds.). Inherited disorders of the thyroid system. Boca Raton: CRC Press, 1994:81-105.
9. Fraser GR, Morgans ME, Trotter WR. The syndrome of sporadic goitre and congenital deafness. Q J Med 1960;29:279-295.
10. Gausden E, Armour JA, Coyle B, Coffey R, Hochberg Z, Pembrey M, Britton KE, Grossman A, Reardon W, Trembath R. Thyroid peroxidase: evidence for disease gene exclusion in Pendred's syndrome. Clin Endocrinol 1996;44:441-446.
11. Reardon W, Coffey R, Phelps PD, Luxon LM, Stephens D, Kendall-Taylor P, Britton KE, Grossman A, Trembath R. Pendred syndrome: 100 years of underascertainement. Q J Med 1997;90:443-447.
12. Cremers CWRJ, Bolder C, Admiraal RJC, Everett LA, Joosten FBM, van Hauwe P, Green ED, Otten BJ. Progressive sensorineural hearing loss and a widened vestibular aqueduct in Pendred syndrome. Arch Otolaryngol Head Neck Surg 1998;124:501-505.
13. Uziel A, Legrand C, Rabie A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. I. Morphological study. Dev Brain Res 1985;19:111-122.
14. O'Malley BW, Li D, Turner DS. Hearing loss and cochlear abnormabilities in the congenital hypothyroid (hyt/hyt) mouse. Hearing Res 1995;88:181-189.
15. Forrest D, Erway L, Ng L, Altschuler R, Curran T. Thyroid hormone receptor ß is essential for development of auditory function. Nature Genetics 1996;13:354-357.
16. Hvidberg-Hansen J, Balslev Jørgensen M. The inner ear in Pendred's syndrome. Acta Oto-laryngol 1968;66:129-135.
17. Phelps PD, Coffey RA, Trembath RC, Luxon LM, Grossman AB, Britton KE, Kendall-Taylor P, Graham JM, Cadge BC, Stephens SG, Pembrey ME, Reardon W. Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998;53:268-273.
18. Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, Green ED, Wilcox ER. A mutation in PDS causes non-syndromic deafness. Nature Genetics 1998;18:215-217.
19. Usami S, Abe S, Weston MD, Shinkawa H, van Camp G, Kimberling WJ. Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999;104:188-192.
20. Baldwin CT, Weiss S, Farrer LA, De Stefano AL, Adair R, Franklyn B, Kidd KK, Korostishevsky M, Bonne-Tamir B. Linkage of congenital, recessive deafness (DFNB4) to chromosome 7q31 and evidence for genetic heterogeneity in the Middle Eastern Druze population. Hum Mol Genet 1995;4:1637-1642.
21. Abe S, Usami S, Hoover DM, Cohn M, Shinkawa H, Kimberling WJ. Fluctuating sensorineural hearing loss associated with enlarged vestibular aqueduct maps to 7q31, the region containing the Pendred gene. Am J Med Genet 1999;82:322-328.
22. Nilsson LR, Borgfors N, Gamstorp I, Holst HE, Lidén G. Non-endemic goitre and deafness. Acta Paed 1964;53:117-131.
23. Kopp P, Karamanoglu Arseven O, Sabacan L, Kotlar T, Dupuis J, Cavaliere H, Santos CLS, Jameson JL, Medeiros-Neto G. Phenocopies for deafness and goiter development in a large inbred kindred with Pendred's syndrome associated with a novel mutation in the PDS gene. J Clin Endocrinol Metab 1999;84:336-341.
24. Vaidya B, Coffey B, Coyle B, Trembath R, San Lazaro C, Reardon W, Kendall-Taylor P. Concurrence of Pendred syndrome, autoimmune thyroiditis, and simple goiter in one family. J Clin Endocrinol Metab 1999;84:2736-2738.
25. Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM, Salameh M, Sadeh O, Glaser B. Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nature Genet 1996;12:424-426.
26. Coyle B, Coffrey R, Armour JAL, Gausden E, Hochberg Z, Grossmann A, Britton K, Pembrey M, Reardon W, Trembath R. Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nature Genet 1996;12:421-423.
27. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nature Genetics 1997;17:411-422.
28. Coyle B, Reardon W, Herbrick JA, Tsui LC, Gausden E, Lee J, Coffey R, Grueters A, Grossman A, Phelps PD, Luxon L, Kendall-Taylor P, Scherer SW, Trembath RC. Molecular analysis of the PDS gene in Pendred syndrome (sensorineural hearing loss and goitre). Hum Mol Genet 1998;7:1105-1112.
29. Everett LA, Morsli H, Wu DK, Green ED. Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci 1999;96:9727-9732.
30. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nature Genet 1999;21:440-443.
31. Kopp P. Pendred's syndrome. Identification of the genetic defect a century after its first clinical description. Thyroid 1999;9:65-69.
32. Kraiem Z, Heinrich R, Sadeh O, Shiloni E, Nassir E, Hazani E, Glaser B. Sulfate transport is not impaired in Pendred syndrome thyrocytes. J Clin Endocrinol Metabol 1999;84:2574-2576.
33. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-460.
34. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 1996;226:339-345.
35. Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML, Ris-Stalpers C, Bolder C, Otten B, de Vijlder JJM, Dietrich NL, Ramesh A, Srisailapathy SCR, Parving A, Cremers CWRJ, Willems PJ, Smith RJH, Green ED, Van Camp G. Two frequent missense mutations in Pendred syndrome. Hum Mol Genet 1998;7:1099-1104.
36. New England Congenital Hypothyroidism Collaborative. Effects of neonatal screening for hypothyroidism: prevention of mental retardation by treatment before clinical manifestation. Lancet 1981;2:1095-1098.
37. Illig R, Largo RH, Qin Q, Torresani T, Rochiccioli P, Larsson A. Mental development in congenital hypothyroidism after neonatal screening. Arch Dis Child 1987;62:1050-1055.
38. LaFranchi S. Congenital hypothyroidism: a newborn screening success story? Endocrinologist 1994;4:477-486.
39. LaFranchi S. Recent developments in pediatric thyroidology. Thyroid today 1998;21:1-13.
40. Kaplan EL, Shukla M, Hara H, Ito K. Developmental abnormalities of the thyroid. In: De Groot LJ (ed.). Endocrinology. Philadelphia: W.B. Saunders, 1994:893-899.
41. Abramowicz MJ, Vassart G, Refetoff S. Probing the cause of thyroid dysgenesis. Thyroid 1997;7:325-326.
42. Kopp P, Jameson JL. Molecular basis of thyroid disease. In: Jameson JL (ed.). Principles of Molecular Medicine. Totowa NJ: Humana Press, 1998:459-473.
43. Niimi H, Inomata H, Sasaki N, Nakajima H. Congenital isolated thyrotrophin releasing hormone deficiency. Arch Dis Child 1982;57:877-878.
44. Katakami H, Kato Y, Inada M, Imura H. Hypothalamic hypothyroidism due to isolated thyrotropin-releasing hormone (TRH) deficiency. J Endocrinol Invest 1984;7:231-233.
45. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T, Hashimoto K, Satoh T, Wakabayashi K, Taketo MM, Mori M. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 1997;94:10862-10867.
46. Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropinreleasing hormone. N Engl J Med 1985;312:1085-1090.
47. Collu R, Tang J, Castagné J, Lagacé G, Masson N, Huot C, Deal C, Delvin E, Faccenda E, Eidne KA, van Vliet G. A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997;82:1361-1365.
48. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990;347:528-533.
49. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;257:1115-1118.
50. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257:1118-1121.
51. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996;384:327-333.
52. Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JAI, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genet 1998;18:147-149.
53. Flück C, Deladoey J, Rutishauser K, Eble A, Marti U, Wu W, Mullis PE. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg→Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998;83:3727-3734.
54. Hayashizaki Y, Hiraoka Y, Tatsumi Y, Hashimoto T, Furuyama J, Miyai K, Nishijo K, Matsura M, Kohno H, Labbe A, Matsubara K. Deoxyribonucleic acid analysis of five families with familial inherited thyroid stimulating hormone deficiency. J Clin Endocrinol Metab 1990;71:792-796.
55. Medeiros-Neto G, Heodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R, Boguszewski MCS, Hollenberg AN, Radovick S, Wondisford FE. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 1996;97:1250-1256.
56. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. New Engl J Med 1995;332:155-160.
57. Refetoff S, Sunthornthepvarakul T, Gottschalk M, Hayashi Y. Resistance to thyrotropin and other abnormabilities of the thyrotropin receptor. Rec Prog Hormone Res 1996;51:97-122.
58. Kopp P. Resistance to TSH. In: Jameson JL (ed.). Hormone resistance syndromes. Totowa: Humana Press, 1999:111-144.
59. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endo 1994;8:129-138.
60. Xie J, Pannain S, Pohlenz J, Weiss RE, Moltz K, Morlot M, Asteria C, Persani L, Beck-Peccoz P, Parma J, Vassart G, Refetoff S. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab 1997;82:3933-3940.
61. Spiegel AM. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996;81:2434-2442.
62. Al-Zahrani A, Levine MA, Schwindinger WF. Pseudohypoparathyroidism. In: Jameson JL (ed.). Hormone resistance syndromes. Totowa: Humana Press, 1999:39-58.
63. Levy O, de la Vieja A, Ginter C, Riedel C, Dai G, Carrasco N. N-linked glycosylation of the thyroid Na + /I- symporter (NIS): implication for its secondary structure. J Biol Chem 1998;273:22657-22663.
64. Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, Takai S, Amino N. Congenital hypothyroidism caused by a mutation in the Na + /A- symporter. Nat Genet 1997;16:124-125.
65. Pohlenz J, Medeiros-Neto G, Gross JL, Silveiro SP, Knobel M, Refetoff S. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/ iodide symporter gene. Biochem Biophys Res Commun 1997;240:488-491.
66. Kosugi S, Bhayana S, Dean HJ. A novel mutation in the sodium/ iodide symporter gene in the largest family with iodide transport defect. J Clin Endocrinol Metab 1999;84:3248-3253.
67. Abramowicz MJ, Targovnik HM, Varela V, Cochaux P, Krawiec L, Pisarev MA, Propato FVE, Juvenal G, Chester HA, Vassart G. Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 1992;90:1200-1204.
68. Bikker H, Vulsma T, Baas F, de Vijlder JJ. Identification of five novel inactivating mutations in the thyroid peroxidase gene by denaturing gradient gel electrophoresis. Human Mutation 1995;6:9-16.
69. Pannain S, Weiss RE, Jackson CE, Dian D, Beck JC, Sheffield VC, Cox N, Refetoff S. Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: power and limits of homozygosity mapping. J Clin Endocrinol Metab 1999;84:1061-1071.
70. Taurog A. Hormone synthesis. In: Braverman LE, Utiger RD (eds.). The thyroid: a fundamental and clinical text. Philadelphia: Lipincott-Raven, 1994:47-81.
71. 5 reductase activity in nontoxic goiter with iodide organification defect. Metabolism 1975;24: 1103-1113.
72. 2 supply in the thyroid of a patient with goiter and iodine organification defect. J Clin Endocrinol Metab 1987;65: 344-348.
73. Medeiros-Neto G, Targovnik HM, Vassart G. Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr Rev 1993;14:165-183.
74. De Vijlder JJM, Baas F, Koch CAM, Kok K, Gons M. Autosomal dominant inheritance of a thyroglobulin abnormality suggests cooperation of subunits in hormone formation. Ann Endocr 1983;44:36.
75. Stanbury JB, Kassenar AAH, Meijer JWA, Terpstra J. The occurrence of mono- and diiodo tyrosine in the blood of a patient with congenital goiter. J Clin Endocrinol Metab 1955; 15:12rem.
76. Damante G, DiLauro R. Thyroid-specific gene expression. Biochim Biophys Acta 1994;1218:255-266.
77. Missero C, Cobellis G, De Felice M, Di Lauro R. Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endo 1998;140:37-43.
78. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631-3639.
79. Mizuno K, Gonzalez FJ, Kimura S. Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1. Mol Cell Biol 1991;11:4927-4933.
80. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10: 60-69.
81. Acebron A, Aza-Blanc P, Rossi DL, Lamas L, Santisteban P. Congenital human thyroglobulin defect due to low expression of the thyroid-specific transcription factor TTF-1. J Clin Invest 1995;96:781-785.
82. Perna MG, Civitareale D, De Filippis V, Sacco M, Cisternino C, Tassi V. Absence of mutations in the gene encoding thyroid transcription factor-1 (TTF-1) in patients with thyroid dysgenesis. Thyroid 1997;7:377-381.
83. Lapi P, Macchia PE, Chiovato L, Biffali E, Moschini L, Larizza D, Baserga M, Pinchera A, Fenzi G, Di Lauro R. Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid 1997;7:383-387.
84. Devriendt K, Vanhole C, Matthis G, De Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. New Engl J Med 1998;338:1317-1318.
85. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997;16:185-197.
86. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K, Macchia PE, Mattei MG, Mariano A, Scholer H, Macchia V, Di Lauro R. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 1998;19:395-398.
87. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, Lazarus JH, Ludgate M, Chatterjee VK. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998;19:399-401.
88. Bamforth JS, Hughes IA, Lazarus JH, Weaver CM, Harper PS. Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 1989;26:49-51.
89. Zannini M, Francis-Lang H, Plachov D, Di Lauro R. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. EMBO J 1992;12:4230-4241.
90. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nature Genet 1998;19:87-90.
91. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Grüters A, Busslinger M, DiLauro R. PAX8 mutations associated with congenital hypothyroidism caused by thyroid agenesis. Nature Genet 1998;19:83-86.
92. Manley NR, Capecchi MR. The role of Hoxa-3 in mouse thymus and thyroid development. Development 1995;121:1989-2003.
93. Manley NR, Capecchi MR. Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Dev Biol 1998;195:1-15.